Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added revision v3.6.4 to the history and removed v3.6.3, reflecting a small update to the page’s version history.
    Difference
    0.1%
    Check dated 2026-07-28T11:26:44.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    A newer revision entry (v3.6.3) was added to the record history and an older revision (v3.6.0) was removed, updating the history to reflect the latest version.
    Difference
    0.1%
    Check dated 2026-06-30T00:57:20.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study record shows recruitment has closed to new participants and the record has been revised to version v3.6.0, replacing the prior v3.5.5 label.
    Difference
    0.4%
    Check dated 2026-06-15T18:22:21.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the study history page.
    Difference
    0.1%
    Check dated 2026-06-08T15:58:36.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The bottom revision stamp updates from v3.5.3 to v3.5.4, reflecting a new revision of the record history. This indicates the study record has been updated.
    Difference
    0.1%
    Check dated 2026-05-18T03:52:56.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Updated the ClinicalTrials.gov interface/revision label from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-26T15:18:01.000Z thumbnail image

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.